At a glance
ClinicalIndex Comparison RecordN/ACompleted· 35 enrolled
Drug / intervention
Patient Navigationbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Undiagnosed Diabetic Retinopathy: Using Participatory Science to Design an Intervention for Patients at High-Risk for Blindness
In Brief
A clinical study evaluating Patient Navigation for Diabetic Retinopathy and Diabetic Blindness. Completed, enrolled 35 participants across 1 site.
Detailed Summary
This is a pilot study of a patient navigator intervention for people living with diabetes and at high risk of diabetic blindness. The investigators are assessing the feasibility and acceptability of the intervention in preparation for a clinical trial.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetic Retinopathy, Diabetic Blindness
CountriesUnited States
CollaboratorsNational Eye Institute (NEI)
Timeline
N/ACompletedFinished
20222023202420252026
First PostedJan 2022
Enrollment StartJul 2022
Primary CompletionSep 2024
TodayJul 2026
First PostedJan 12, 2022
Enrollment StartJul 25, 2022
Primary CompletionSep 19, 2024
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 4.5 years ago
Interventions
Patient Navigationbehavioral
Participants will be assigned to a patient navigator and will have quarterly appointments. Patient navigators will assist with access and coordination of medical care.